Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
03/1999
03/11/1999WO1999011283A1 Method for treating a subject suffering from conditions associated with an extracellular zinc sphingomyelinase
03/11/1999WO1999011264A1 Il-8 receptor antagonists
03/11/1999WO1999011253A1 Il-8 receptor antagonists
03/11/1999WO1998042847A3 Papilloma virus main capsid protein and the use thereof in diagnosis, therapy and vaccination
03/11/1999WO1998033509A3 Useful properties of human lactoferrin and variants thereof
03/11/1999DE19739685A1 Monoklonale Antikörper zur Therapie und Prophylaxe von Erkrankungen durch Clostridium difficile Monoclonal antibodies for the therapy and prophylaxis of diseases caused by Clostridium difficile
03/11/1999CA2303295A1 5,5-disubstituted-1,5-dihydro-4,1-benzoxazepin-2(3h)-ones useful as hiv reverse transcriptase inhibitors
03/11/1999CA2302505A1 Vaginal suppository vaccine for urogenital infections
03/11/1999CA2302450A1 Il-8 receptor antagonists
03/11/1999CA2302364A1 Il-8 receptor antagonists
03/11/1999CA2302168A1 Method for treating a subject suffering from conditions associated with an extracellular zinc sphingomyelinase
03/11/1999CA2301642A1 3-descladinose 6-o-substituded erythromycin derivatives
03/11/1999CA2300046A1 N-terminal modifications of rantes and methods of use
03/11/1999CA2294074A1 Parp inhibitors, pharmaceutical compositions comprising same, and methods of using same
03/10/1999EP0900848A2 MecB polynucleotides and polypeptides from the Clpc ATPase family of Stapyloccoccus aureus
03/10/1999EP0900847A2 Phosphoribosyl transferase from Staphylococcus aureus
03/10/1999EP0900846A2 Nucleic acid encoding Streptococcus pneumoniae response regulator
03/10/1999EP0900845A2 Signal recognition particle polypeptides and polynucleotides
03/10/1999EP0900844A2 Membrane protein of Staphylococcus aureus
03/10/1999EP0900843A2 FfH polypeptide from Streptococcus
03/10/1999EP0900797A1 1-methylcarbapenem derivatives
03/10/1999EP0900789A2 Substituted quinolone derivatives and pharmaceuticals containing the same
03/10/1999EP0900375A1 Pharmaceutical grade botanical drugs
03/10/1999EP0900371A1 Systems and methods for quantifying photoreactions in light activated materials
03/10/1999EP0900272A2 Tumor necrosis factor alpha convertase
03/10/1999EP0900210A1 Antivirally active heterocyclic azahexane derivatives
03/10/1999EP0900197A1 Beta-thiopropionyl-aminoacid derivatives and their use as beta-lactamase inhibitors
03/10/1999EP0900089A1 Biological material free of viral and molecular pathogens and a process for the production thereof
03/10/1999EP0900083A1 Novel substituted imidazole compounds
03/10/1999EP0900081A1 Inhibitors of farnesyl-protein transferase
03/10/1999EP0900079A1 Use of 3-amino-4-hydroxybenzoic acid for the treatment of retroviral infections
03/10/1999EP0773951B1 Dinucleoside-5',5'-pyrophosphates
03/10/1999EP0677039B1 Cyclobutane derivatives as inhibitors of squalene synthetase and protein farnesyltransferase
03/10/1999EP0505400B1 N-substituted naphthalamides, their production and use
03/10/1999CN1210558A Recombinant phages
03/10/1999CN1210540A Triazole derivatives useful in therapy
03/10/1999CN1210539A Cephem compounds and pharmaceutical use thereof
03/10/1999CN1210470A Vacciness against varicella zoster virus gene 63 product
03/10/1999CN1042428C Preparation of 1-N-ethylsisomicin
03/10/1999CN1042425C 3-hydroxy-4-hydroxymethyl-2-methylenecyclopentyl purines and pyrimidines
03/10/1999CN1042424C Process for converting loracarbef dihydrate to loracarbef monohydrate
03/10/1999CA2243670A1 Novel histidine kinase
03/09/1999US5880283 8-alkoxyquinolonecarboxylic acid hydrate with excellent stability and process for producing the same
03/09/1999US5880280 Aryl, alkyl, alkenyl and alkynylmacrolides having immunosuppressive activity
03/09/1999US5880163 Oil composition of dihydropolyprenols
03/09/1999US5880106 Containing water insoluble antacid buffering composition combined with dihydroxyaluminum alkali metal carbonate or calcium carbonate, optional excipients; improved bioavailability, reduced side effects
03/09/1999US5880104 Administering a plasmid vector encoding a fusion protein lacking a transmembrane region
03/09/1999US5880097 Tethered prodrugs
03/09/1999US5879952 43 Kd protein vaccine and method for the production thereof
03/09/1999US5879706 Valaciclovir tablets containing colloidal silicon dioxide
03/09/1999US5879700 Treating herpes virus infections
03/09/1999US5879688 Treatment of skin disorders, wrinkling, aging
03/09/1999US5879686 Administering refolded trimeric meningococcal group b porin protein-polysaccharide conjugate to raise immune response in animal
03/09/1999US5879683 Antibacterial agent containing tea extract or active fraction thereof and β-lactam antibiotic
03/09/1999US5879675 Opsonizing tumor cell obtained from animal by incubating in presence of alpha-galactosyl epitope and glycosphingolipids to insert epitope into cell membrane, irradiating cell, administering to animal
03/09/1999US5878747 Condom coated with acidic polysaccharides
03/09/1999CA2243656A1 Response regulator
03/09/1999CA2038279C Cd25 binding molecules
03/09/1999CA1340424C Substituted vinylcephalosporins, processes for their preparation and their use as medicaments
03/09/1999CA1340422C Anthracycline derivatives having cytostatic activity
03/04/1999WO1999010497A1 Novel mutants of gram negative mucosal bacteria and application thereof in vaccines
03/04/1999WO1999010496A1 Tuberculosis vaccine
03/04/1999WO1999010475A2 Attenuated strains of mycobacteria
03/04/1999WO1999010375A2 Vaccine against hpv
03/04/1999WO1999010374A1 Cyclosporin a conjugates and uses therefor
03/04/1999WO1999010373A1 Non-immunosuppressive cyclosporins and their use in the prevention and treatment of hiv infection
03/04/1999WO1999010372A1 Molecular mimetics of meningococcal b epitopes
03/04/1999WO1999010371A2 Cyclopeptide derivatives as adhesion inhibitors
03/04/1999WO1999010360A1 Oligosaccharide derivatives and process for producing the same
03/04/1999WO1999010348A1 Optionally protected 3-hydroxymethyl carbapenems and synthesis
03/04/1999WO1999010343A1 Oxazolidinone derivatives and their use as antibacterial agents
03/04/1999WO1999010342A1 Antibiotic oxazolidinone derivatives
03/04/1999WO1999010324A1 AZETIDINONE DERIVATIVES AS β-LACTAMASE INHIBITORS
03/04/1999WO1999010292A2 Robustaflavone, intermediates and analogues and method for preparation thereof
03/04/1999WO1999010012A1 NOVEL priA
03/04/1999WO1999010006A1 Therapy for staphylococcus aureus
03/04/1999WO1999009990A1 Pharmaceutical suspension comprising nevirapine hemihydrate
03/04/1999WO1999009985A1 Inhibitors of prenyl-protein transferase
03/04/1999WO1999009984A1 Pyrrolidine and piperidine modulators of chemokine receptor activity
03/04/1999WO1999009975A1 4-cyano-4-deformylsordaricin derivatives
03/04/1999WO1999009974A1 4-cyano-4-deformylsordarin derivatives
03/04/1999WO1999009968A1 Ophthalmic compositions for soft contact lens, method of enhancing wettability of soft contact lens, and method of inhibiting terpenoid adsorption
03/04/1999WO1998055606A3 Lactoferrin receptor genes of moraxella
03/04/1999WO1998019648A3 N-oxy-naphthalimides as antibacterial agents
03/04/1999CA2316412A1 Attenuated strains of mycobacteria
03/04/1999CA2301893A1 Oligosaccharide derivatives and process for producing the same
03/04/1999CA2301879A1 Tuberculosis vaccine
03/04/1999CA2301770A1 Inhibitors of prenyl-protein transferase
03/04/1999CA2301589A1 Therapy for staphylococcus aureus
03/04/1999CA2301523A1 Azetidinone derivatives as .beta.-lactamase inhibitors
03/04/1999CA2301519A1 Ophthalmic compositions for soft contact lens, method of enhancing wettability of soft contact lens, and method of inhibiting terpenoid adsorption
03/04/1999CA2301515A1 Optionally protected 3-hydroxymethyl carbapenems and synthesis
03/04/1999CA2301182A1 Cyclopeptide derivatives
03/04/1999CA2298813A1 Pyrrolidine and piperidine modulators of chemokine receptor activity
03/04/1999CA2245755A1 2-(arylphenyl)amino-imidazoline derivatives
03/04/1999CA2242260A1 Spo0j1
03/04/1999CA2242258A1 Novel compounds
03/04/1999CA2242254A1 Novel tig
03/03/1999EP0899339A1 The Chlamydia trachomatis Glutamyl-tRNAGln amidotransferase subunit ratB
03/03/1999EP0899338A2 Seryl tRNA synthetase of Streptococcus pneumoniae (serS)
1 ... 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 1531 1532 1533 1534 1535 1536 1537 1538 1539 ... 1798